Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterial ATP synthase subunit c (AtpE) is an essential component of the membrane-embedded Fo domain of the F1Fo-ATP synthase complex in mycobacteria, including Mycobacterium tuberculosis. It forms a homomeric oligomeric ring (c-ring) that acts as a rotor, coupling the transmembrane proton-motive force to the synthesis of ATP in the catalytic F1 domain. This energy-generating mechanism is vital for both actively replicating and dormant, non-replicating mycobacteria.
The c-ring is the primary target of the diarylquinoline class of antitubercular drugs, most notably bedaquiline. Bedaquiline binds to the interface of the c-subunits, blocking proton translocation and halting ATP production, which leads to bacterial cell death. Mutations in the atpE gene can lead to high-level drug resistance, making it a critical focus for monitoring and the development of next-generation ATP synthase inhibitors.
Inhibition of the mycobacterial F1Fo-ATP synthase by binding to the oligomeric subunit c (c-ring) of the Fo domain, which blocks the rotation of the rotor and prevents proton translocation, thereby halting ATP synthesis and depleting cellular energy.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial ATP synthase subunit c (AtpE).